General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Glenn GM et al. – If toxins truly exert barrier disruptive effects as a key step in pathogenesis, then a return to classic toxin–based vaccine strategies for enteric disease is both warranted, and can be expected to have unexpectedly broad protective effects.

Related Articles

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09    Relevance Score: 99%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09    Relevance Score: 97%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09    Relevance Score: 97%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09    Relevance Score: 96%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09    Relevance Score: 95%

Today in Vaccine/Immunotherapy...keeping you current

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09

A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address